×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Upsher-Smith Enhances Generics Portfolio by Introducing Difluprednate Ophthalmic Emulsion
By
Upsher-Smith Laboratories, LLC
Upsher-Smith Laboratories, LLC
24 Sep 2025
European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
By
Alteogen Inc.
Alteogen Inc.
17 Sep 2025
Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships
By
Sanguine Biosciences
Sanguine Biosciences
17 Sep 2025
LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology
By
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc.
16 Sep 2025
Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)
By
Novocure
Novocure
16 Sep 2025
At the American Thyroid Association meeting, FORE Biotherapeutics presented Phase 1/2a data for Plixorafenib, demonstrating a prolonged duration of effect in BRAF-altered thyroid cancers
By
FORE Biotherapeutics
FORE Biotherapeutics
15 Sep 2025
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Pharmaceutical
2nd International Conference on Stem Cells and Regenerative Medicine 2025
10 Nov 2025
10:00 am
- 11 Nov 2025
5:30 pm
USA
Pharmaceutical
2nd International Conference on Immunology & Vaccination 2025
10 Nov 2025
10:00 am
- 12 Nov 2025
5:30 pm
Paris
Most Popular
Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)
By
Bracco Group
Nov 11
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
By
Upsher-Smith Laboratories
Mar 29
SciTech Development announces the second FDA approval of a Phase 1 A/B IND for ST-001, which now targets the treatment of relapsed/refractory small cell lung cancer, following its previous approval for the treatment of T-cell NHL
By
SciTech Development, Inc.
Apr 08
October
2025
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
